Company profilePharmaceutical#443 of 1,318 in Pakistan1 DRAP alert

AIMS PHARMACEUTICALS

Pharmaceutical company · 35 brands · 39 molecules

Ranked #120 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

35 registered products 15 pharmaceutical brands 39 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

AIMS PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 35 product registrations across 39 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Other Beta-Lactam, Cephalosporins & Penems. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by AIMS

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Antimycotics Systemic Use 3

Flucoaim150mgRs 114 TERBIAIM10 GRs 293.55 TerbiaimRs 293.55

Anti-Acne Preparations 1

Accutane20mgRs 760

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 1

Esoaim40mgRs 17.51

Top molecules by brand count

Fusidic Acid2 brands

Terbinafine2 brands

Iron Polymaltose Complex2 brands

Oxaprozin1 brand

Azithromycin1 brand

Moxifloxacin1 brand

Clopidogrel1 brand

Mecobalamin1 brand

Ofloxacin1 brand

Adapalene1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

DVAGO4 products · Rs 17.51 – Rs 760

Servaid1 products · Rs 590 – Rs 590

Median across source: Rs 590

Regulatory record

1 alert in the DRAP feed we track.

19. Recall Alert – WHO Recall Class-II

2026-04-14

Competitive set

Companies whose registered portfolio overlaps most with this one.

SHROOQ PHARMACEUTICALS20 shared molecules

GENOME PHARMACEUTICALS (PVT) LTD19 shared molecules

VALOR PHARMACEUTICALS17 shared molecules

MEDERA PHARMACEUTICALS (PVT) LTD.17 shared molecules

Horizon Pharmaceuticals (Pvt) Limited17 shared molecules

BIO LABS (PVT) LTD.16 shared molecules

Wilshire Laboratories (Private) Limited16 shared molecules

FYNK PHARMACEUTICALS16 shared molecules

GETZ PHARMA PAKISTAN (PVT) LTD.16 shared molecules

DANAS PHARMACEUTICALS (PVT) LTD15 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 21 molecules not in this portfolio

GENOME PHARMACEUTICALS (PVT) LTD holds 111 molecules not in this portfolio

VALOR PHARMACEUTICALS holds 156 molecules not in this portfolio

Get the full profile for AIMS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included